APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CCNL1 | Cyclin L1 | Predicted secreted proteins
| | | | | Tissue enriched |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDT1 | Chromatin licensing and DNA replication factor 1 | Disease related genes
| | | | | Tissue enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | | | | | | Tissue enhanced |
CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 | | | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EXO1 | Exonuclease 1 | | | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | | | | | | Tissue enhanced |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | | | | | | Tissue enhanced |
GRAP2 | GRB2-related adaptor protein 2 | Plasma proteins
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | | | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
H1FX | H1 histone family, member X | Plasma proteins
| | | | | Tissue enriched |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes
| | | | | Tissue enriched |
HIST1H2AB | Histone cluster 1, H2ab | | | | | | Tissue enhanced |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HIST1H3H | Histone cluster 1, H3h | | | | | | Tissue enhanced |
HJURP | Holliday junction recognition protein | | | | | | Tissue enhanced |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Transcription factors
| | | | | Tissue enhanced |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KAZN | Kazrin, periplakin interacting protein | | | | | | Tissue enhanced |
KIAA0101 | KIAA0101 | Mitochondrial proteins
| | | | | Tissue enhanced |
KIAA0226L | KIAA0226-like | | | | | | Tissue enhanced |
MEF2B | Myocyte enhancer factor 2B | Transcription factors
| | | | | Group enriched |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ORC1 | Origin recognition complex, subunit 1 | Disease related genes
| | | | | Tissue enhanced |
PASK | PAS domain containing serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | | | Tissue enhanced |